A vs REGN · P/E 29, rev $1.88B vs P/E 14, rev $14.34B
Agilent Technologies Inc (A) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
A currently screens at market cap $33.70B and trailing P/E 29.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the A and REGN stock pages for the full models.
Not investment advice.